My Account
11th-Dec-2023 09:18Source: BSE
Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus and Daewoong Pharmaceuticals announce exclusive licensing agreement for development and commercialization of Leuprolide Long-Acting Injectable in the U.S.
More Announcements on:
27th-Dec-2023 14:33Source: NSE
27th-Dec-2023 14:26Source: BSE
Zydus Lifesciences - Disclosure Under Regulation 30 Of SEBI LODR, 2015
27th-Dec-2023 14:26Source: BSE
Zydus Lifesciences - Disclosure Under Regulation 30 Of SEBI LODR, 2015
26th-Dec-2023 21:46Source: BSE
26th-Dec-2023 21:46Source: BSE
26th-Dec-2023 15:43Source: BSE
26th-Dec-2023 15:43Source: BSE
22nd-Dec-2023 16:26Source: BSE
Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release
21st-Dec-2023 11:58Source: BSE
Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Newspaper Publication
21st-Dec-2023 11:58Source: BSE
Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Newspaper Publication
DID YOU INVEST?
Powerful mix of both trader and investor packs with timely expert advice.
Designed especially for traders looking to tap the profit opportunities of volatile markets.
For all investors looking to unearth stocks that are poised to move.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
You are already a Moneycontrol Pro user.